Skip to main content
. 2019 Jul 31;30(10):1973–1982. doi: 10.1007/s00198-019-05097-1

Fig. 3.

Fig. 3

Kaplan-Meier estimated risk and relative risk (bisphosphonate users versus controls) of death in the matched cohort during the first 30 days after initiation of bisphosphonate (BP) treatment. In the bottom panel, the solid line indicates relative risk and the dashed lines indicate 95% confidence intervals